Cargando…
JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL
T-cell prolymphocytic leukemia (T-PLL) is a rare and poor-prognostic mature T-cell leukemia. Recent studies detected genomic aberrations affecting JAK and STAT genes in T-PLL. Due to the limited number of primary patient samples available, genomic analyses of the JAK/STAT pathway have been performed...
Autores principales: | Wahnschaffe, Linus, Braun, Till, Timonen, Sanna, Giri, Anil K., Schrader, Alexandra, Wagle, Prerana, Almusa, Henrikki, Johansson, Patricia, Bellanger, Dorine, López, Cristina, Haferlach, Claudia, Stern, Marc-Henri, Dürig, Jan, Siebert, Reiner, Mustjoki, Satu, Aittokallio, Tero, Herling, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966610/ https://www.ncbi.nlm.nih.gov/pubmed/31766351 http://dx.doi.org/10.3390/cancers11121833 |
Ejemplares similares
-
Advances and Perspectives in the Treatment of T-PLL
por: Braun, Till, et al.
Publicado: (2020) -
The miR-141/200c-STAT4 Axis Contributes to Leukemogenesis by Enhancing Cell Proliferation in T-PLL
por: Otte, Moritz, et al.
Publicado: (2023) -
The dawn of a new era in treating T-PLL
por: Schrader, Alexandra, et al.
Publicado: (2019) -
P1228: GENOME-WIDE CRISPR-CAS9 SCREENING IDENTIFIES THERAPEUTIC TARGETS FOR MATURE T-CELL MALIGNANCIES
por: Timonen, Sanna, et al.
Publicado: (2023) -
SynToxProfiler: An interactive analysis of drug combination synergy, toxicity and efficacy
por: Ianevski, Aleksandr, et al.
Publicado: (2020)